Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
Sana Biotechnology, Inc. (SANA)
Company Research
Source: Seeking Alpha
Steven Harr - President, CEO & Director Conference Call Participants Reni Benjamin - Citizens JMP Securities, LLC, Research Division Presentation Reni Benjamin Citizens JMP Securities, LLC, Research Division All right. We'll go ahead and get started. So good afternoon, everyone, and welcome to the second day of the Citizens Life Science Conference for the first time here in Miami. It's my pleasure to introduce Sana Biotechnology and presenting for the company or chatting with us about the company is CEO, Steve Harr. Steve, welcome, and thank you for this. Question-and-Answer Session Reni Benjamin Citizens JMP Securities, LLC, Research Division I never know exactly who's in the audience or who's listening on the webcast, whether they know the Sana story or not. And so I'd love to start off maybe in 2 to 4 minutes with an overview of Sana before we dive into some specific questions. Steven Harr President, CEO & Director Sure. First of all, thank you for having
Show less
Read more
Impact Snapshot
Event Time:
SANA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SANA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SANA alerts
High impacting Sana Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
SANA
News
- Sana Biotechnology (SANA) had its "overweight" rating reaffirmed by Morgan Stanley.MarketBeat
- Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression [Yahoo! Finance]Yahoo! Finance
- Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without ImmunosuppressionGlobeNewswire
- Sana Biotechnology (SANA) was downgraded by Zacks Research from "strong-buy" to "hold".MarketBeat
- Sana Biotechnology (SANA) had its price target lowered by HC Wainwright from $9.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
SANA
Earnings
- 8/11/25 - Beat
SANA
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/6/26 - Form 4
- SANA's page on the SEC website